NCT05194111 2026-03-13
TREAT-HF
Virginia Commonwealth University
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT03872778 2026-01-28
NeoRay
Advanced Accelerator Applications
Phase 1/2 Completed
NCT06236061 2026-01-13
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Novartis
Phase 3 Completed
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT03647657 2022-02-10
177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Completed
NCT04092309 2020-04-03
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
University of Athens
Phase NA Unknown
NCT01569815 2015-10-19
Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function
Novartis
Phase 1 Completed